Postdoc in Cancer Epigenetics
at Syddansk Universitet
Odense, Region Syddanmark, Denmark -
Start Date | Expiry Date | Salary | Posted On | Experience | Skills | Telecommute | Sponsor Visa |
---|---|---|---|---|---|---|---|
Immediate | 21 Jan, 2025 | Not Specified | 21 Oct, 2024 | N/A | Developmental Biology,Cell Culture,Genomics,Gene Regulation,Confocal Microscopy,Cancer Biology,Molecular Biology,Biochemistry,Computer Skills,Epigenetics,Functional Analysis,Immunostaining,Bioinformatics,Models | No | No |
Required Visa Status:
Citizen | GC |
US Citizen | Student Visa |
H1B | CPT |
OPT | H4 Spouse of H1B |
GC Green Card |
Employment Type:
Full Time | Part Time |
Permanent | Independent - 1099 |
Contract – W2 | C2H Independent |
C2H W2 | Contract – Corp 2 Corp |
Contract to Hire – Corp 2 Corp |
Description:
Applications are invited for a position of postdoc in Cancer Epigenetics in the laboratory of DNRF Chair and Novo Nordisk Faculty Professor Vijay Tiwari ( https://www.tiwarilab.org/ ).
The position is available - initially for six months - from January 1, 2025, or as soon as possible thereafter - with the possibility of extension for three years.
The postdoc will lead research on gene regulatory mechanisms underlying cancer metastasis and drug resistance and will support Professor Tiwari in smooth running of the laboratory at various levels. The group employs cutting-edge molecular biology, epigenetics and genomics tools in combination with computational biology approaches to generate comprehensive models of gene regulation during carcinogenesis.
To learn more, please refer to the selected publications from the Tiwari lab:
Science Advances, 2024, Jun 7;10(23):eadn1640; EMBO Mol Medicine, 2024, Apr ; 16(4):823-853 ; Nature Communications , 2024, 11;15(1):1870; npj Precision Oncology , 2024, Mar 12;8(1):64; Nature Cell Biology , 2022, 24, 1265–1277; Genes & Development , 2020, Sep; 34(17-18):1190-1209; Nature, 2019, Mar; 567(7746):113-117; Cell Stem Cell , 2018, Oct 4; 23(4):557; Nature Communications, 2017 Nov 15;8(1):1523; The EMBO Journal , 2016 Jan 4;35(1):24-45; J Cell Science , 2015 Dec 1;128(23):4380-94; The EMBO Journal , 2015 Aug 13;34(16):2162-81; Genome Research , 2015 Sep;25(9):1309-24; Nature Communications , 2013, Sep 27; 4:2478; Cancer Cell , 2013, 23, 768-783; PNAS , 2012 Apr 17;109(16): E934-43; Nature Genetics , 2012 Jan; 18;44(1):94-100; Nature , 2011 Dec 14;480 (7378):490-5.
ESSENTIAL QUALIFICATIONS
- PhD in molecular biology, epigenetics, chromatin biology, genomics, cancer biology, biochemistry, developmental biology or related areas.
- At least one first-author publication, accepted or submitted
- Strong analytical, organizational, and record-keeping skills
- Proficient computer skills, including MS Office and research software programs
- Interest in working in a multidisciplinary and multicultural team
- Willing to collaborate with internal and external collaborators as well as support group members
DESIRED QUALIFICATIONS
- Basic understanding of cancer biology and gene regulation
- Conceptual grip on cancer genetics, epigenetics and gene regulation
- Experience in cell culture as well as basic and advanced molecular biology techniques
- Familiarity with organoids\spheroids and mouse models
- Prior experience with perturbation-based functional analysis (e.g. shRNA, CRISPR-Cas9).
- Familiarity with drug sensitivity assays and screening
- Expertise in tissue sectioning, immunostaining and advanced imaging e.g. confocal microscopy
- Basic understanding of Bioinformatics would be an advantage
Responsibilities:
Please refer the Job description for details
REQUIREMENT SUMMARY
Min:N/AMax:5.0 year(s)
Pharmaceuticals
Pharma / Biotech / Healthcare / Medical / R&D
Clinical Pharmacy
Phd
Proficient
1
Odense, Denmark